ReviewResuscitation plus2026
Multi-omics in cardiac arrest: a systematic review.
Review in Resuscitation plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac arrest (CA) poses significant public health challenges, with high incidence and mortality rates. Characterized by its rapid progression and high mortality, there is a lack of effective pharmacotherapy for CA, making prevention and early intervention crucial. Advancements in genomics, transcriptomics, proteomics, and metabolomics offer profound insights into the pathophysiology and etiology of CA, potentially leading to novel diagnostic biomarkers and therapeutic targets. This comprehensive review explores recent advancements in omics technologies and their applications in understanding CA, highlighting the role of genetic variations, RNA transcripts, protein profiles, and metabolites in CA. It also addresses the limitations of current studies and proposes future directions for omics research in unraveling the complexities of CA. This review aims to advance our understanding of CA and pave the way for precision treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.